Iyer N Gopalakrishna, Kim Leslie, Nixon Iain J, Palmer Frank, Kraus Dennis, Shaha Ashok R, Shah Jatin P, Patel Snehal G, Ganly Ian
Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA.
Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1240-7. doi: 10.1001/archoto.2010.213.
to report our experience in the care of patients with minor salivary gland cancers occurring only in the oropharynx and to determine factors predictive of outcome.
Retrospective analysis.
memorial Sloan-Kettering Cancer Center.
sixty-seven patients with malignant minor salivary gland tumors were identified from a preexisting database of patients with cancers of the oropharynx between January 1985 and December 2005.
overall survival, disease-specific survival, and recurrence-free survival were calculated by the Kaplan-Meier method. Factors predictive of outcome were identified by univariate and multivariate analyses.
the most common histologic types were mucoepidermoid carcinoma in 26 patients (39%), adenoid cystic carcinoma in 16 (24%), adenocarcinoma in 16 (24%), and malignant mixed tumor in 7 (10%). The tumors were located in the base of the tongue in 41 patients (61%), soft palate in 20 (30%), and tonsil in 6 (9%). With a median follow-up time of 86 months (range, 12-249 months), overall outcomes at 5 and 10 years were overall survival, 80% and 53%; disease-specific survival, 87% and 67%; and recurrence-free survival, 69% and 60%, respectively. Tumor recurred in 20 patients (34%); 12 of these patients had locoregional failure and 15 developed distant metastases. Multivariate analyses showed that clinical T stage, anatomic subsite, and margin status were independent predictors for overall survival; T stage and margin status were independent predictors for locoregional recurrence-free survival.
clinical T stage, anatomic subsite, and margin status are independent predictors of outcome of patients with minor salivary gland cancers of the oropharynx.
报告我们对仅发生于口咽的小唾液腺癌患者的护理经验,并确定预后的预测因素。
回顾性分析。
纪念斯隆凯特琳癌症中心。
从1985年1月至2005年12月已有的口咽癌患者数据库中识别出67例患有恶性小唾液腺肿瘤的患者。
采用Kaplan-Meier法计算总生存期、疾病特异性生存期和无复发生存期。通过单因素和多因素分析确定预后的预测因素。
最常见的组织学类型为黏液表皮样癌26例(39%),腺样囊性癌16例(24%),腺癌16例(24%),恶性混合瘤7例(10%)。肿瘤位于舌根41例(61%),软腭20例(30%),扁桃体6例(9%)。中位随访时间为86个月(范围12 - 249个月),5年和10年的总体结果分别为:总生存期80%和53%;疾病特异性生存期87%和67%;无复发生存期69%和60%。20例患者(34%)出现肿瘤复发;其中12例患者有局部区域失败,15例发生远处转移。多因素分析显示,临床T分期、解剖亚部位和切缘状态是总生存期的独立预测因素;T分期和切缘状态是局部区域无复发生存期的独立预测因素。
临床T分期、解剖亚部位和切缘状态是口咽小唾液腺癌患者预后的独立预测因素。